Eurazeo seizes chance for poison pill defence

Eurazeo, the Paris-based private equity group, has become one of the first French companies to adopt a poison pill defence clause against a hostile bid under the country's new takeover rules.

At its annual general meeting last Friday the company voted through the right to issue stock warrants to shareholders in the event of an approach.

WSJ Logo